National Alliance for Eye and Vision Research
Advocacy Center
Become an Advocate for Vision Research
Eye Fact Center
Press Center
Newsletters
Spread the Word
Tell Your Story
Link to Our Site
Resources and Links
Privacy Policy
Site Map

NAEVR Logo


NAEVR Announces Release of
The Silver Book: Vision Loss


NAEVR Supports World Glaucoma Day


NAEVR Participates in White House Conference on Aging

Serving as Friends of the National Eye Institute


Breaking News

NAEVR Praises Senate's Economic Stimulus Bill for Increased Funding for NIH

NAEVR Praises $3.9 billion NIH Funding in House Economic Stimulus Bill

DOD Announces FY2008 PRMRP Awards for Clinical and Translational Vision Research

NIH Issues Biennial Report with Numerous References to NEI-Funded Vision Research

NAEVR/AEVR Announce Early 111th Congress Events

NAEVR Releases Fall 2008 Contributor Report

Dr. Kington Briefs NIH Council of Councils on NIH Priorities

Champions Urge Medical Research Funding in Economic Stimulus

As Dr. Zerhouni Leaves, Dr. Kington becomes Acting Director Amidst Other Senior Staff Changes

For First Time, Peer Reviewed Vision Research Listed as Separate Line Item in DOD Medical Research Program

NIH/NEI Flat Funded in FY2009 Continuing Resolution, But Vision Research Increases by $6.5 Million Over FY2007

NIH Medline Plus Magazine Highlights Eye and Vision Health

Dr. Elias Zerhouni to step down as Director of the National Institutes of Health

NIH Director Dr. Elias Zerhouni Updates Congress on Status of NIH Reauthorization Legislation

NAEVR Releases Summer 2008 Contributor Report

AEVR’s September 16 AMD Briefing Concurrent with Anticipated Congressional Action on Research Funding

AEVR Co-Sponsors Lighthouse International Congressional Briefing on Diabetes and Vision Loss

NIH Distributes $150 Million Supplemental NIH Funding, NEI to Receive $3.5 Million to FY2008 Funding Total of $670.7 Million

Congress Adjourns for Summer Recess, Will Return in September with Most FY2009 Appropriations Bills Still Unfinished

Senators Introduce $5.2 Emergency Supplemental Bill for NIH; NIH Director Zerhouni Testifies Before Senate Appropriations Subcommittee

Congress Acts to Increase FY2008 and FY2009 NIH Funding

AEVR and FFB Announce Congressional Briefing on Initial Results of Human Gene Therapy Trials for LCA

AEVR/NAEVR Announce Speakers for the June 9 15th Anniversary Congressional Reception Featuring Release of Vision and Blindness Fact Sheet with Research!America

NAEVR Joins the Vision Community in Requesting Vision Objectives in Healthy People 2020

Senate Approves Supplemental with $400 Million for NIH

As NAEVR Submits Senate Testimony Regarding FY2009 NIH/NEI Funding, Researcherss Report Initial Results of Human Gene Therapy Trials Cited as an Example of NEI's Public/Private Collaborations

NAEVR Releases Spring 2008 Contributor Report

Senior VA and DOD Representatives Confirm Development of Military Eye Trauma Center of Excellence and Registry

House Investigates Incidence of and Care for TBI-Related Vision Disorders

DOD Issues Funding Opportunities Notice with June and July 2008 Submission Deadlines

NAEVR Cites Latest NEI Research and Collaborations in House Testimony Regarding FY2009 NIH/NEI Funding

179 House Members Support Increased FY2009 NIH Funding in Letter to Appropriations Leaders

Senate Passes Amendment to Increase FY2009 NIH Funding as House Holds Citizen Witness Hearing

NIH Director Dr. Zerhouni Testifies Before House on FY2009 Budget

NAEVR Releases Winter 2008 Contributor Report

NAEVR Posts World Glaucoma Day Web Page, Announces Plans to Spend March 6 on Capitol Hill

NAEVR Announces Support for Glaucoma Awareness Events in March 2008

NAEVR Issues Quarterly E-ZINE (February 2008)

* * *

Click here to see older Breaking News Items


The U.S. Congress should adequately fund eye and vision research at the NEI. Eye and vision disease is now at epidemic proportions. As of the year 2000 census, more than 119 million Americans age 40+ were at risk from age-related eye disease, such as age-related macular degeneration, diabetic retinopathy, glaucoma and cataracts. More than 35 million Americans age 40+ currently experience these diseases, in addition to the 3.4 million who are blind, and this number is expected to grow to 50 million by the year 2020. A growing Hispanic and African American population is experiencing a disproportionate incidence of glaucoma and cataracts. And, the epidemic of diabetes is increasing the onset of diabetic retinopathy, the leading cause of blindness in individuals 25-74 years in age.

 

About the Alliance National Eye Institute Contact Us
Become an Advocate for Vision Research - Join the Action List
Speak Up for Eye and Vision Research
Enter Your Zip Code   

Your Candidates Your Health Your Candidates
Your Health
See Where Your Elected Representatives Stand on Medical Research

NAEVR in Action


 
ARVO Researchers Make FY2010 Funding Requests for Vision Research
Left to right: Dr. Cowan, Dr. Gagliano, and NEI Director Paul Sieving, M.D., Ph.D.

 
NAEVR Hosts Drs Gagliano and Cowan in Visits with Community and use image with Dr Sieving
Colonel Donald Gagliano. M.D. (center) with NAEVR Board member David Pyott (left), Chairman of the Board and Chief Executive Officer, Allergan, Inc., and NAEVR President Stephen Ryan, M.D. (right), Doheny Eye Institute

 
NAEVR Board Hosts Dr. Don Gagliano, new Director of the Military Eye Trauma Vision Center of Excellence
Gregory Hageman, Ph.D.

 
AEVR Congressional Briefing Highlights AMD Awareness Week 2008
left to right: Dr. Bruce Rosenthal, Dr. Tara Cortes, Dr. Neil M. Bressler, and Nicole Pedone

 
AEVR joins with Lighthouse International to Educate Hill About Diabetes and Vision Loss
NAEVR Advocacy Manager David Epstein with Col. Robert Mazzoli

 
NAEVR Attends Military Traumatic Eye Injury Symposium; DOD Announces Additional FY2008 Vision Research Funding
Researchers Describe Initial Results of Human Gene Therapy Trials for Blinding Eye Diseases

 
Researchers Describe Initial Results of Human Gene Therapy Trials for Blinding Eye Diseases
Congress, NIH Recognize AEVR/NAEVR Anniversary

 

Congress, NIH Recognize AEVR/NAEVR Anniversary
James Jorkasky comments on the importance of senior vision health

 
NAEVR Joins the Vision Community in Requesting Vision Objectives in Healthy People 2020
Program Co-Chairs Robert N. Weinreb, M.D. (left) and Paul Kaufman, M.D. (right) with NEI Director Paul Sieving, M.D., Ph.D.

 
NEI and FDA Address Glaucoma Clinical Trials with Vision Community

Click Here for Print Version
AGS President Robert Weinreb, M.D. (Hamilton Glaucoma Center/University of California San Diego), Cong. Pete Sessions (R-TX), and Advocacy Day Program Co-Chair Anne Coleman, M.D. (Jules Stein Eye Institute/University of California Los Angeles)

 
NAEVR Joins AGS in Advocacy and Education on World Glaucoma Day
Using Real-time OCT, AEVR Educates Capitol Hill on Visual Imaging Technologies  Revolutionizing the Diagnosis and Treatment of Eye Disease

 
AEVR Educates Hill on Visual Imaging Using Real-time OCT
ARVO Researchers Make FY2009 Funding Requests for Vision Research

 
ARVO Researchers Make FY2009 Funding Requests for Vision Research
Dr. Lenworth Johnson and NIH Director Elias Zerhouni

 
NEI’s Trans-Institute Research Praised, Vision Community Represented in Initial Meeting of Council to Guide NIH Common Fund
NEI Director Dr. Sieving Educates Capitol Hill about Rare Eye Diseases

 
NEI Director Dr. Sieving Educates Capitol Hill about Rare Eye Diseases

* * *

Click here to see older NAEVR in Action Items



Americans spend more than $68 Billion in healthcare costs associated with eye and vision disorders, yet our annual federal investment in research to find effective treatments and therapies is less than 1% of that number.

  Site Designed by:  Site Designed by e-advocates